KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInvested CapitalMarket Capitalization

AbCellera Biologics (ABCL) Return on Assets: 2021-2023

Historic Return on Assets for AbCellera Biologics (ABCL) over the last 3 years, with Dec 2023 value amounting to -0.10%.

  • AbCellera Biologics' Return on Assets fell 20.00% to -0.10% in Q4 2023 from the same period last year, while for Dec 2023 it was -0.10%, marking a year-over-year decrease of 20.00%. This contributed to the annual value of -0.11% for FY2024, which is 2.00% down from last year.
  • Latest data reveals that AbCellera Biologics reported Return on Assets of -0.10% as of Q4 2023, which was down 15.22% from -0.08% recorded in Q3 2023.
  • AbCellera Biologics' 5-year Return on Assets high stood at 0.26% for Q1 2021, and its period low was -0.10% during Q4 2023.
  • In the last 3 years, AbCellera Biologics' Return on Assets had a median value of 0.12% in 2021 and averaged 0.09%.
  • Data for AbCellera Biologics' Return on Assets shows a maximum YoY dropped of 24bps (in 2023) over the last 5 years.
  • Over the past 3 years, AbCellera Biologics' Return on Assets (Quarterly) stood at 0.12% in 2021, then declined by 2bps to 0.10% in 2022, then declined by 20bps to -0.10% in 2023.
  • Its Return on Assets was -0.10% in Q4 2023, compared to -0.08% in Q3 2023 and -0.05% in Q2 2023.